Delving into the Latest Updates on MSCs eye drops(Nanjing Drum Tower Hospital) with Synapse

Overview

Basic Info

Drug Type

Mesenchymal stem cell therapy

Synonyms-

Target-

Action-

Mechanism

Stem cell replacements

Therapeutic Areas-

Active Indication-

Inactive Indication-

Originator Organization

Nanjing Drum Tower Hospital

Active Organization

Nanjing Drum Tower Hospital

Inactive Organization-

License Organization-

Drug Highest PhaseEarly Phase 1

First Approval Date-

Regulation-

Login to view timeline

The goal of this non-randomized, prospective, open, one-arm clinical study is to learn about the clinical efficacy of stem cell eye drops in patients with dry eye disease (DED) who failed to respond to artificial tear sodium hyaluronate eye drops three times a day for two weeks.
The main question aims to answer are:
How effective are stem cell eye drops in patients with DED?
How safe are stem cell eye drops for patients with DED? Participants will be treated with mesenchymal stem cells (MSCs) eye drops, 5×10^5 /50μl in each eye, twice a day for two weeks and they will be followed up for three months after treatment.

Start Date01 Jun 2023

Sponsor / Collaborator

Nanjing Drum Tower Hospital

ChiCTR2300071953

/ RecruitingPhase 1

Evaluation of the efficacy and safety of Golden Eye Drops for the treatment of dry eye - a multicenter, randomized, double-blind, placebo-controlled post-market clinical trial.

Start Date01 Jun 2023

Sponsor / Collaborator